Candel Therapeutics, Inc.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase I…
Biotechnology
US, Needham [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Candel Therapeutics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCandel Therapeutics, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Candel Therapeutics, Inc..
If you want to see a demo, head over to the financial segments of AAPL